期刊文献+

纤维蛋白原Bβ-455G/A多态性与颈动脉粥样硬化斑块的相关性研究

Relationship between the Ppolymorphism of β-fibrinogen Gene-455G/A and Carotid Artery Atherosclerotic Plaque
下载PDF
导出
摘要 目的研究纤维蛋白原Bβ(fibrinogen Bβ,FGB)基因启动子区域-455G/A变异与颈动脉粥样硬化斑块的关系。方法缺血性中风病人160例,其中颈动脉粥样硬化斑块病人68例(斑块组),颈动脉未见粥样硬化斑块者92例(非斑块组),应用多聚酶链反应加HaeⅢ内切酶检测FGB启动子区域-455G/A的多态性,血浆纤维蛋白原水平测定采用凝血酶原时间法,颈动脉斑块采用超声检测。结果A-455等位基因在斑块组的分布频率为0.17较非斑块组0.07明显增高(χ2=7.67,P<0.01)。不同组别的基因型的分布不同,G/A、A/A基因型在斑块组更常见(χ2=6.59,P<0.05)。斑块组血浆纤维蛋白原水平(4.82±1.21)g/L显著高于非斑块组(4.27g/L±0.90g/L,P<0.01)。结论血浆中纤维蛋白原水平受FGB基因-455G/A多态性的影响,A-455等位基因是颈动脉粥样硬化斑块形成的危险因素。 Objective To study the association between the variation of β - figrinogen gene promoter - 455G/A and carotid artery atherosclerotic plaque. Methods One hundred and sixty patients with ischemic stroke were divided into plaque group (n=68), non - plaque group (n= 92). Polymerase chain reaction with restrictive enzyme HaeⅢ (PCR- R LP method) was used to analyze the poly- morphism of β-figrinogen gene promoter-455G/A. Plasma fibrinogen levels were measured with prothrombin time (PT) test. Ca- rotid artery atherosclerotie plaque was detected with ultrasound. Results A-455 allele frequencies in the plaque group (0.17) were significantly higher than that in the non- plaque group (0.07, χ^2 = 7.67,P〈0.01). The gcnetypes were significant difference in different groups (χ^2=6.59, P〈0.05). The mean fibrinogen levels in plaque group (4.82 ±1.21) g/L were significantly higher than that in non - plaque group(4. 27 g/L±0. 90 g/L, t=3.29 ,P〈0.01). Conclusion Plasma fibrinogen level could be affected by the β- fibrinogen gene - 455G/A polymorphism. And A - 455 allele might be an independent risk factor for carotid artery atherosclerotic plaque.
出处 《中西医结合心脑血管病杂志》 2008年第10期1149-1151,共3页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
关键词 纤维蛋白原 基因多态性 颈动脉粥样硬化斑块 fibrinogen gene polymorphism carotid artery atherosclerotic plaque
  • 相关文献

参考文献11

  • 1Grant PJ. Polymorphisms of coagulation/fibrin olysis genes: Gene evironment interactions and cascular risk[J].Prostagtandins Leukotrienes & Essential Fatty Acids, 1997,57 : 473 - 477.
  • 2Wilhelmsen L, Svardsud DK, Korsan B,et al. Fibrinogen as a risk faefor for stroke and mycardial infaretion[J]. N Engl J Med, 1984, 311:501-505.
  • 3Ernst Koening EW. Fibrinogen and cardiovascular risk[J]. Vasc Med,1997,2:115 - 125.
  • 4Gardemann A, Schwartz O, Haberbosch W. Positive assoliation of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction[J]. Thromb Haemost,1997, 77(6) : 1120 - 1126.
  • 5Humphries SE, Cook M, Dubowits M. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations[J]. Lancet, 1987,1 : 1452 - 1455.
  • 6Nishiuma S, Kario K, Yakushijin K. Genetic variation in the promoter region of the 13 - fibrinogen gene is associated with ischemic stroke in Japanese population[J]. Blood Coagulation and Fibrinolysis, 1998,9 : 373 - 379.
  • 7Sehminke U, Motsch L, Griewing B, et al. Three - dimensional power-mode ultrasound for quantification of the progression of carotid artery atherosclerosis[J].J Neurol, 2000,247 : 106 - 111.
  • 8Krobot K, Hense HW, Cremer P. Determinants of plasma fibrinogen: Relation to Joody weight, waist - to - hip ratio, smoking, alcohol, age and sex. Result from the second MONICA August survey 1989 - 1990[J]. Arterioscler Thromb, 1992,12 : 780 - 788.
  • 9Sandset PM, Andersson TR. Coagulation inhibitor levels in pneumonia and stroke:Changes due to consumption and acute phase realtion[J].J Intern Med,1989,225:311 -316.
  • 10Thomas AE,Green FR, Humphries SE. Association of genetic variation at the beta fibrinogen gene locus and plasma fibrinogen levels: Interaction between allele frequency of the G/A- 455 pol- ymorphism, age and smoking[J]. Clin Genet, 1996,50:184 - 190.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部